<?xml version='1.0' encoding='utf-8'?>
<document id="31993509"><sentence text="Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein."><entity charOffset="38-46" id="DDI-PubMed.31993509.s1.e0" text="eribulin" /></sentence><sentence text="This study examined the effects of microtubule-targeting anticancer drugs (paclitaxel, cabazitaxel, and eribulin) on the expression of drug efflux transporter P-glycoprotein, which is encoded by MDR1"><entity charOffset="75-85" id="DDI-PubMed.31993509.s2.e0" text="paclitaxel" /><entity charOffset="87-98" id="DDI-PubMed.31993509.s2.e1" text="cabazitaxel" /><entity charOffset="104-112" id="DDI-PubMed.31993509.s2.e2" text="eribulin" /><pair ddi="false" e1="DDI-PubMed.31993509.s2.e0" e2="DDI-PubMed.31993509.s2.e0" /><pair ddi="false" e1="DDI-PubMed.31993509.s2.e0" e2="DDI-PubMed.31993509.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31993509.s2.e0" e2="DDI-PubMed.31993509.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31993509.s2.e1" e2="DDI-PubMed.31993509.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31993509.s2.e1" e2="DDI-PubMed.31993509.s2.e2" /></sentence><sentence text=" Paclitaxel and eribulin induced MDR1 promoter activity in a concentration-dependent manner, while cabazitaxel had little effect in human intestinal epithelial LS174T cells"><entity charOffset="1-11" id="DDI-PubMed.31993509.s3.e0" text="Paclitaxel" /><entity charOffset="16-24" id="DDI-PubMed.31993509.s3.e1" text="eribulin" /><entity charOffset="99-110" id="DDI-PubMed.31993509.s3.e2" text="cabazitaxel" /><pair ddi="false" e1="DDI-PubMed.31993509.s3.e0" e2="DDI-PubMed.31993509.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31993509.s3.e0" e2="DDI-PubMed.31993509.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31993509.s3.e0" e2="DDI-PubMed.31993509.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31993509.s3.e1" e2="DDI-PubMed.31993509.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31993509.s3.e1" e2="DDI-PubMed.31993509.s3.e2" /></sentence><sentence text=" Overexpression of the nuclear receptor pregnane X receptor (PXR) gene (NR1I2) enhanced paclitaxel- and eribulin-induced MDR1 activation, but expression of the nuclear receptor co-repressor silencing mediator for retinoid and thyroid receptors (SMRT) gene (NCOR2) repressed MDR1 activation" /><sentence text=" Eribulin increased the mRNA and protein expression of P-glycoprotein in LS174T cells" /><sentence text=" Cellular uptake of rhodamine 123 and calcein-acetoxymethyl ester (calcein-AM), P-glycoprotein substrates, decreased in paclitaxel- or eribulin-treated LS174T cells"><entity charOffset="38-65" id="DDI-PubMed.31993509.s6.e0" text="calcein-acetoxymethyl ester" /></sentence><sentence text=" Eribulin also increased MDR1 promoter activity in human breast cancer MCF7 cells" /><sentence text=" The results suggest that the microtubule-targeting anticancer drug eribulin can induce the drug efflux transporter P-glycoprotein via PXR in human intestinal and breast cancer cells and thus influence the efficacy of anticancer drugs"><entity charOffset="68-76" id="DDI-PubMed.31993509.s8.e0" text="eribulin" /></sentence><sentence text="" /></document>